Background: Suppression of plasma viremia by antiretroviral therapy (ART) is generally associated with improvements in immunological status, but some individuals fail to achieve normalization of CD4 T cell counts. In adults, AIDS defining events rapidly decrease once virological suppression is achieved, even when CD4 T cell lymphocytopenia persists. Similar data are not available for children to determine the frequency of and risks associated with persistence of CD4 lymphocytopenia despite effective ART. Methodology: Data were pooled from 3,784 children enrolled in the 219C, NISDI and AMP cohorts, and 933 perinatally HIV-1 infected youth were identified with virologic suppression (VS) lasting at least 1 year at an age of >5 years, with available CD4 counts. For each child’s first period of virologic suppression (VS) (plasma HIV RNA < 400 copies/ml), piecewise linear regression models were used to examine CD4 T cell trajectories during VS by CD4 at start of VS and Kaplan-Meier estimates for time to CD4≥500 cells/μL were generated for CD4 categories < 500 copies/μL. Results: Of the 933 children in the study population, 50% were black, 36% Hispanic/Latino, and 14% white/Asian with a median age of 8.8 years at the start of ART that resulted in VS. 108 (12%) were from NISDI sites in Argentina, Brazil, Mexico, and Peru; 88% were from the United States and Puerto Rico. At the start of ART leading to VS, 92 (10%), 118 (13%), and 138 (15%) had CD4 T cell counts of <200, 200-350, and 350-499 cells/μL, respectively. Most (99%) children achieved a CD4 count of 200 cells/μL after 1 year of VS, but 13% failed to exceed 500 cells/μL. The rate of initial increase in CD4 T cells counts was inversely proportional to baseline CD4 T cell strata. The median times to first CD4 T cell counts > 500/μL were 15, 9, and 6 months for children with <200, 200-350, and 350-499 CD4+ T cells/μL at the time of VS (Figure). CDC C events occurred in 8 children after VS, including encephalopathy, bacterial peritonitis, pneumonia, and candida esophagitis. 3 such events occurred in the first 6 months following VS; the others occurred 6.6 to 21 months after VS. 5 events were in children with CD4 T cell counts> 500 cells/μL. Conclusions: Most children who maintain virological suppression improve their CD4 T cell counts. The time to achieving a CD4 count of > 500 T cells/μL is highly variable and depends upon CD4 counts at the start of VS. Although rare, AIDS defining events continued to occur in 1% of the population studied, despite VS and improved T cell counts.